Lappe Mark

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lappe Mark's trades of Inhibrx Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-16
B Purchase
60,473 -16.3%
82.33
US$1,105,707 		60,473 -16.3% 82.33 US$1,105,707
2024-09-16 2024-09-12
B Purchase
80,352 +1.9%
113.00
US$1,282,126 		80,352 +1.9% 113.00 US$1,282,126
2024-09-10 2024-09-10
B Purchase
32,920 +41.1%
137.23
US$1,507,887 		32,920 +41.1% 137.23 US$1,507,887
2024-09-10 2024-09-09
B Purchase
9,500 +1.5%
15.21
US$144,495 		9,500 +1.5% 15.21 US$144,495
2024-09-10 2024-09-06
B Purchase
26,000 +4.2%
15.29
US$397,540 		26,000 +4.2% 15.29 US$397,540
2024-09-03 2024-09-03
B Purchase
4,712 +2.9%
16.31
US$76,853 		4,712 +2.9% 16.31 US$76,853
2024-09-03 2024-09-03
B Purchase
15,288 +10.5%
15.66
US$239,410 		15,288 +10.5% 15.66 US$239,410
2024-09-03 2024-08-30
B Purchase
10,000 +7.4%
14.02
US$140,200 		10,000 +7.4% 14.02 US$140,200
2024-09-03 2024-08-29
B Purchase
10,000 +8.0%
14.03
US$140,300 		10,000 +8.0% 14.03 US$140,300
2024-08-22 2024-08-21
B Purchase
12,945 +30.9%
12.93
US$167,379 		12,945 +30.9% 12.93 US$167,379
2024-08-22 2024-08-20
B Purchase
27,055 +182.0%
12.97
US$350,903 		27,055 +182.0% 12.97 US$350,903
2023-03-01 2023-02-28
US Inhibrx Inc (INBX)
PlS Planned sale
60 -0.0%
25.02
US$1,501 		60 -0.0% 25.02 US$1,501
2023-01-24 2023-01-24
US Inhibrx Inc (INBX)
PlS Planned sale
63 -0.0%
26.11
US$1,645 		63 -0.0% 26.11 US$1,645
2023-01-24 2023-01-24
US Inhibrx Inc (INBX)
PlS Planned sale
4,272 -0.2%
25.71
US$109,833 		4,272 -0.2% 25.71 US$109,833
2023-01-24 2023-01-23
US Inhibrx Inc (INBX)
PlS Planned sale
21,665 -0.9%
25.36
US$549,364 		21,665 -0.9% 25.36 US$549,364
2022-12-20 2022-12-19
US Inhibrx Inc (INBX)
PlS Planned sale
754 -0.0%
26.29
US$19,820 		754 -0.0% 26.29 US$19,820
2022-12-20 2022-12-19
US Inhibrx Inc (INBX)
PlS Planned sale
25,246 -1.0%
25.53
US$644,624 		25,246 -1.0% 25.53 US$644,624
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
1,150 -0.0%
32.38
US$37,241 		1,150 -0.0% 32.38 US$37,241
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
912 -0.0%
30.67
US$27,969 		912 -0.0% 30.67 US$27,969
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
6,773 -0.3%
30.15
US$204,196 		6,773 -0.3% 30.15 US$204,196
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
1,767 -0.1%
28.86
US$50,991 		1,767 -0.1% 28.86 US$50,991
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
4,333 -0.2%
27.45
US$118,937 		4,333 -0.2% 27.45 US$118,937
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
4,106 -0.2%
26.57
US$109,098 		4,106 -0.2% 26.57 US$109,098
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
6,959 -0.3%
25.36
US$176,477 		6,959 -0.3% 25.36 US$176,477
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
121 -0.0%
31.51
US$3,812 		121 -0.0% 31.51 US$3,812
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
2,892 -0.1%
30.81
US$89,090 		2,892 -0.1% 30.81 US$89,090
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
14,006 -0.5%
29.92
US$419,123 		14,006 -0.5% 29.92 US$419,123
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
8,981 -0.3%
28.66
US$257,419 		8,981 -0.3% 28.66 US$257,419